about
α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB)Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective studySymptoms and signs in interpreting gamma-hydroxybutyrate (GHB) intoxication - an explorative study.Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results.Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.Suppression by γ-Hydroxybutyric Acid of "Alcohol Deprivation Effect" in Rats: Preclinical Evidence of its anti-Relapse PropertiesNeuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patientsLiquid ecstasy - a significant drug problem.New synthesis and tritium labeling of a selective ligand for studying high-affinity γ-hydroxybutyrate (GHB) binding sites.Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters.Gamma-hydroxybutyric acid (GHB) measurement by GC-MS in blood, urine and gastric contents, following an acute intoxication in Belgium.The labeling of unsaturated γ-hydroxybutyric acid by heavy isotopes of hydrogen: iridium complex-mediated H/D exchange by C─H bond activation vs reduction by boro-deuterides/tritides.Nurse's perspectives on care provided for patients with gamma-hydroxybutyric acid and gamma-butyrolactone abuse.Detection of gamma hydroxybutyrate in emergency department: Nice to have or a valuable diagnostic tool?Injection port silylation of γ-hydroxybutyrate and trans-hydroxycrotonic acid: conditions optimisation and characterisation of the di-tert-butyldimethylsilyl derivatives by GC-MS.
P2860
Q28270141-23E79ADA-3CBE-47CA-BCB9-F95CEE8CD4D2Q28275217-2CF94477-6CD9-4345-8004-22FA33CE7538Q33575947-EBA26C9C-0737-4C97-AAA5-9C6C9FC51187Q34165511-D88BF121-068E-4AFE-A408-48E3362A8734Q34168958-E3633074-E779-4540-B57F-3C67F9535B36Q34389840-7B2327B0-F231-424A-8795-700E9867CA9EQ35587438-CEBFF453-9EF0-4564-B9C5-95F057332EF4Q35710620-AF386F7E-B933-4D24-8F61-1FB6AF336FAFQ36370079-C5F9598F-4A8B-4E3F-9ED8-080350606F60Q36925650-512F7AB7-6D9B-4BDD-82F9-82255ACF5192Q37188098-06ACAAB1-505C-4416-8FF7-5B7C5792F53CQ37466884-48452F86-C570-4D06-96CD-D5742A3C7E0DQ38166827-19BF2E41-CCE2-4016-9D2B-7DE74AED683EQ39048315-8E1C25F6-B03C-4AA7-B0F1-A6B7DAB999DCQ42565505-3FDAFC2A-41B9-44EE-B6CF-B6EE4504B6BBQ44597346-CFF3A91F-00C7-45B9-B6A9-27B8FA50BFB9Q46493579-37724C9A-8977-42E1-95FC-EB85920A9F4FQ46738738-6251BA7F-CBD8-41D6-86B2-F2CC2D9D12A9Q47649801-27EBB63D-2270-45BA-8A95-0897A6B73553Q48214656-EAF3584F-263B-4C26-B586-4F28CF680FFD
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Gamma-hydroxybutyrate--a drug of abuse.
@ast
Gamma-hydroxybutyrate--a drug of abuse.
@en
type
label
Gamma-hydroxybutyrate--a drug of abuse.
@ast
Gamma-hydroxybutyrate--a drug of abuse.
@en
prefLabel
Gamma-hydroxybutyrate--a drug of abuse.
@ast
Gamma-hydroxybutyrate--a drug of abuse.
@en
P2093
P2860
P1476
Gamma-hydroxybutyrate--a drug of abuse.
@en
P2093
Christensen J
Drasbek KR
P2860
P304
P356
10.1111/J.1600-0404.2006.00712.X
P407
P577
2006-09-01T00:00:00Z